Author: Gerstein, Shawn; Gautam-Goyal, Pranisha; Goyal, Sameer
Title: A case of Listeria monocytogenes meningitis complicated by Hydrocephalus and Intraventricular hemorrhage: A review of treatment options and outcomes Document date: 2020_1_18
ID: j7mcry3l_9
Snippet: The use of intrathecal/intraventricular antimicrobials in this setting has not been well studied. A review of the existing literature reveals no standard protocol for the administration of intraventricular antimicrobials in the setting of CNS infections [10] . The risk reward profile focuses on the advantages of higher doses of antimicrobials in the CSF than can cross the blood brain barrier alone versus the increased risk of toxicity. A clinical.....
Document: The use of intrathecal/intraventricular antimicrobials in this setting has not been well studied. A review of the existing literature reveals no standard protocol for the administration of intraventricular antimicrobials in the setting of CNS infections [10] . The risk reward profile focuses on the advantages of higher doses of antimicrobials in the CSF than can cross the blood brain barrier alone versus the increased risk of toxicity. A clinical cohort study by Shoft and colleagues found a mortality benefit with no significant adverse events when utilizing intraventricular antimicrobials alongside systemic antimicrobials in a population of postneurosurgical patients [11] . A case report by Richards and colleagues demonstrated the efficacy of using intraventricular antimicrobials in a patient with recurrent Listeria monocytogenes meningitis following treatment failure with systemic therapy alone [12] .
Search related documents:
Co phrase search for related documents- adverse event and blood brain barrier: 1
- adverse event and blood brain barrier cross: 1
- adverse event and case report: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adverse event and clinical cohort: 1, 2, 3, 4, 5, 6
- adverse event and clinical cohort study: 1, 2, 3
- adverse event and high dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adverse event and increase risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- blood brain and case report: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- blood brain and clinical cohort: 1
- blood brain and CNS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- blood brain and high dose: 1, 2
- blood brain and increase risk: 1, 2, 3
- blood brain barrier and case report: 1, 2, 3, 4, 5
- blood brain barrier and CNS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- blood brain barrier and high dose: 1, 2
- blood brain barrier and increase risk: 1, 2
- blood brain barrier cross and case report: 1, 2
- blood brain barrier cross and CNS infection: 1, 2
- blood brain barrier cross and increase risk: 1
Co phrase search for related documents, hyperlinks ordered by date